Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cyclosporine in Traumatic Brain Injury (TRACK-TBI PM-003)
NCT06790095Phase 2Enrolling by invitation
- Sponsor
- University of California, San Francisco
- Start
- Jul 2026
- Primary completion
- Mar 2027
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cyclosporine in traumatic brain injury (TBI), sponsored by University of California, San Francisco. Started Jul 2026; status: enrolling by invitation.
02
Drugs
cyclosporine
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on NCT06790095.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06790095.